Department of Genetics, Faculty of Medical Sciences, New University of Lisbon, Rua da Junqueira 96, P-1349-008 Lisboa, Portugal.
BMC Cancer. 2009 Sep 25;9:344. doi: 10.1186/1471-2407-9-344.
MMR is responsible for the repair of base-base mismatches and insertion/deletion loops. Besides this, MMR is also associated with an anti-recombination function, suppressing homologous recombination. Losses of heterozygosity and/or microsatellite instability have been detected in a large number of skin samples from breast cancer patients, suggesting a potential role of MMR in breast cancer susceptibility.
We carried out a hospital-based case-control study in a Caucasian Portuguese population (287 cases and 547 controls) to estimate the susceptibility to non-familial breast cancer associated with some polymorphisms in mismatch repair genes (MSH3, MSH4, MSH6, MLH1, MLH3, PMS1 and MUTYH).
Using unconditional logistic regression we found that MLH3 (L844P, G>A) polymorphism GA (Leu/Pro) and AA (Pro/Pro) genotypes were associated with a decreased risk: OR = 0.65 (0.45-0.95) (p = 0.03) and OR = 0.62 (0.41-0.94) (p = 0.03), respectively.Analysis of two-way SNP interaction effects on breast cancer revealed two potential associations to breast cancer susceptibility: MSH3 Ala1045Thr/MSH6 Gly39Glu - AA/TC [OR = 0.43 (0.21-0.83), p = 0.01] associated with a decreased risk; and MSH4 Ala97Thr/MLH3 Leu844Pro - AG/AA [OR = 2.35 (1.23-4.49), p = 0.01], GG/AA [OR = 2.11 (1.12-3,98), p = 0.02], and GG/AG [adjusted OR = 1.88 (1.12-3.15), p = 0.02] all associated with an increased risk for breast cancer.
It is possible that some of these common variants in MMR genes contribute significantly to breast cancer susceptibility. However, further studies with a large sample size will be needed to support our results.
MMR 负责修复碱基对错配和插入/缺失环。除此之外,MMR 还与抗重组功能有关,抑制同源重组。在大量乳腺癌患者的皮肤样本中已经检测到杂合性丢失和/或微卫星不稳定性,这表明 MMR 在乳腺癌易感性中可能起作用。
我们在一个葡萄牙白种人人群中进行了一项基于医院的病例对照研究(287 例病例和 547 例对照),以估计非家族性乳腺癌与错配修复基因(MSH3、MSH4、MSH6、MLH1、MLH3、PMS1 和 MUTYH)中一些多态性相关的易感性。
使用无条件逻辑回归,我们发现 MLH3(L844P、G>A)多态性 GA(亮氨酸/脯氨酸)和 AA(脯氨酸/脯氨酸)基因型与降低的风险相关:OR = 0.65(0.45-0.95)(p = 0.03)和 OR = 0.62(0.41-0.94)(p = 0.03)。对乳腺癌的双向 SNP 相互作用效应分析显示,有两个潜在的关联与乳腺癌易感性有关:MSH3 Ala1045Thr/MSH6 Gly39Glu-AA/TC [OR = 0.43(0.21-0.83),p = 0.01] 与降低的风险相关;以及 MSH4 Ala97Thr/MLH3 Leu844Pro-AG/AA [OR = 2.35(1.23-4.49),p = 0.01]、GG/AA [OR = 2.11(1.12-3.98),p = 0.02]和 GG/AG [调整后的 OR = 1.88(1.12-3.15),p = 0.02] 均与乳腺癌风险增加相关。
这些 MMR 基因中的一些常见变体可能对乳腺癌易感性有重要贡献。然而,需要更大样本量的进一步研究来支持我们的结果。